Report Cover

Global and Japan Weight Loss Therapeutics Market Size, Status and Forecast 2021-2027


Global Weight Loss Therapeutics Scope and Market Size
Weight Loss Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Weight Loss Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Appetite Suppression
    Increasing Body Metabolism
    Interfering with the Digestion Absorption Patterns

Segment by Application
    Hospitals
    Specialized Clinics
    Retail Pharmacies
    Mail Order Pharmacies
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    Abbott
    Sanofi
    Novo Nordisk
    Arena Pharmaceuticals
    Orexigen Therapeutics
    Johnson & Johnson
    Pfizer
    Novartis AG
    Biocon
    VIVUS
    Eli Lilly
    Amgen
    Zafgen
    Roche
    Eisai
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Appetite Suppression
        1.2.3 Increasing Body Metabolism
        1.2.4 Interfering with the Digestion Absorption Patterns
    1.3 Market by Application
        1.3.1 Global Weight Loss Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Specialized Clinics
        1.3.4 Retail Pharmacies
        1.3.5 Mail Order Pharmacies
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Weight Loss Therapeutics Market Perspective (2016-2027)
    2.2 Weight Loss Therapeutics Growth Trends by Regions
        2.2.1 Weight Loss Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Weight Loss Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Weight Loss Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Weight Loss Therapeutics Industry Dynamic
        2.3.1 Weight Loss Therapeutics Market Trends
        2.3.2 Weight Loss Therapeutics Market Drivers
        2.3.3 Weight Loss Therapeutics Market Challenges
        2.3.4 Weight Loss Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Weight Loss Therapeutics Players by Revenue
        3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
    3.4 Global Weight Loss Therapeutics Market Concentration Ratio
        3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2020
    3.5 Weight Loss Therapeutics Key Players Head office and Area Served
    3.6 Key Players Weight Loss Therapeutics Product Solution and Service
    3.7 Date of Enter into Weight Loss Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Weight Loss Therapeutics Breakdown Data by Type
    4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2022-2027)

5 Weight Loss Therapeutics Breakdown Data by Application
    5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Weight Loss Therapeutics Market Size (2016-2027)
    6.2 North America Weight Loss Therapeutics Market Size by Type
        6.2.1 North America Weight Loss Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Weight Loss Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Weight Loss Therapeutics Market Size by Type (2016-2027)
    6.3 North America Weight Loss Therapeutics Market Size by Application
        6.3.1 North America Weight Loss Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Weight Loss Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Weight Loss Therapeutics Market Size by Application (2016-2027)
    6.4 North America Weight Loss Therapeutics Market Size by Country
        6.4.1 North America Weight Loss Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Weight Loss Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Weight Loss Therapeutics Market Size (2016-2027)
    7.2 Europe Weight Loss Therapeutics Market Size by Type
        7.2.1 Europe Weight Loss Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Weight Loss Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Weight Loss Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Weight Loss Therapeutics Market Size by Application
        7.3.1 Europe Weight Loss Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Weight Loss Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Weight Loss Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Weight Loss Therapeutics Market Size by Country
        7.4.1 Europe Weight Loss Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Weight Loss Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Weight Loss Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Weight Loss Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Weight Loss Therapeutics Market Size (2016-2027)
    9.2 Latin America Weight Loss Therapeutics Market Size by Type
        9.2.1 Latin America Weight Loss Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Weight Loss Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Weight Loss Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Weight Loss Therapeutics Market Size by Application
        9.3.1 Latin America Weight Loss Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Weight Loss Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Weight Loss Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Weight Loss Therapeutics Market Size by Country
        9.4.1 Latin America Weight Loss Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Weight Loss Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Weight Loss Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Weight Loss Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Weight Loss Therapeutics Introduction
        11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Weight Loss Therapeutics Introduction
        11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.2.5 Sanofi Recent Development
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
        11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.3.5 Novo Nordisk Recent Development
    11.4 Arena Pharmaceuticals
        11.4.1 Arena Pharmaceuticals Company Details
        11.4.2 Arena Pharmaceuticals Business Overview
        11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
        11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.4.5 Arena Pharmaceuticals Recent Development
    11.5 Orexigen Therapeutics
        11.5.1 Orexigen Therapeutics Company Details
        11.5.2 Orexigen Therapeutics Business Overview
        11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
        11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.5.5 Orexigen Therapeutics Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
        11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Weight Loss Therapeutics Introduction
        11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.7.5 Pfizer Recent Development
    11.8 Novartis AG
        11.8.1 Novartis AG Company Details
        11.8.2 Novartis AG Business Overview
        11.8.3 Novartis AG Weight Loss Therapeutics Introduction
        11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.8.5 Novartis AG Recent Development
    11.9 Biocon
        11.9.1 Biocon Company Details
        11.9.2 Biocon Business Overview
        11.9.3 Biocon Weight Loss Therapeutics Introduction
        11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.9.5 Biocon Recent Development
    11.10 VIVUS
        11.10.1 VIVUS Company Details
        11.10.2 VIVUS Business Overview
        11.10.3 VIVUS Weight Loss Therapeutics Introduction
        11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.10.5 VIVUS Recent Development
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Details
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
        11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.11.5 Eli Lilly Recent Development
    11.12 Amgen
        11.12.1 Amgen Company Details
        11.12.2 Amgen Business Overview
        11.12.3 Amgen Weight Loss Therapeutics Introduction
        11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.12.5 Amgen Recent Development
    11.13 Zafgen
        11.13.1 Zafgen Company Details
        11.13.2 Zafgen Business Overview
        11.13.3 Zafgen Weight Loss Therapeutics Introduction
        11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.13.5 Zafgen Recent Development
    11.14 Roche
        11.14.1 Roche Company Details
        11.14.2 Roche Business Overview
        11.14.3 Roche Weight Loss Therapeutics Introduction
        11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.14.5 Roche Recent Development
    11.15 Eisai
        11.15.1 Eisai Company Details
        11.15.2 Eisai Business Overview
        11.15.3 Eisai Weight Loss Therapeutics Introduction
        11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.15.5 Eisai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Appetite Suppression Table 3. Key Players of Increasing Body Metabolism Table 4. Key Players of Interfering with the Digestion Absorption Patterns Table 5. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Weight Loss Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Weight Loss Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Weight Loss Therapeutics Market Share by Regions (2016-2021) Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Weight Loss Therapeutics Market Share by Regions (2022-2027) Table 11. Weight Loss Therapeutics Market Trends Table 12. Weight Loss Therapeutics Market Drivers Table 13. Weight Loss Therapeutics Market Challenges Table 14. Weight Loss Therapeutics Market Restraints Table 15. Global Weight Loss Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Weight Loss Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2020) Table 18. Ranking of Global Top Weight Loss Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Weight Loss Therapeutics Product Solution and Service Table 22. Date of Enter into Weight Loss Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Weight Loss Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Weight Loss Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Weight Loss Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbott Company Details Table 63. Abbott Business Overview Table 64. Abbott Weight Loss Therapeutics Product Table 65. Abbott Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 66. Abbott Recent Development Table 67. Sanofi Company Details Table 68. Sanofi Business Overview Table 69. Sanofi Weight Loss Therapeutics Product Table 70. Sanofi Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 71. Sanofi Recent Development Table 72. Novo Nordisk Company Details Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Weight Loss Therapeutics Product Table 75. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 76. Novo Nordisk Recent Development Table 77. Arena Pharmaceuticals Company Details Table 78. Arena Pharmaceuticals Business Overview Table 79. Arena Pharmaceuticals Weight Loss Therapeutics Product Table 80. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 81. Arena Pharmaceuticals Recent Development Table 82. Orexigen Therapeutics Company Details Table 83. Orexigen Therapeutics Business Overview Table 84. Orexigen Therapeutics Weight Loss Therapeutics Product Table 85. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 86. Orexigen Therapeutics Recent Development Table 87. Johnson & Johnson Company Details Table 88. Johnson & Johnson Business Overview Table 89. Johnson & Johnson Weight Loss Therapeutics Product Table 90. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 91. Johnson & Johnson Recent Development Table 92. Pfizer Company Details Table 93. Pfizer Business Overview Table 94. Pfizer Weight Loss Therapeutics Product Table 95. Pfizer Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 96. Pfizer Recent Development Table 97. Novartis AG Company Details Table 98. Novartis AG Business Overview Table 99. Novartis AG Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 100. Novartis AG Recent Development Table 101. Biocon Company Details Table 102. Biocon Business Overview Table 103. Biocon Weight Loss Therapeutics Product Table 104. Biocon Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 105. Biocon Recent Development Table 106. VIVUS Company Details Table 107. VIVUS Business Overview Table 108. VIVUS Weight Loss Therapeutics Product Table 109. VIVUS Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 110. VIVUS Recent Development Table 111. Eli Lilly Company Details Table 112. Eli Lilly Business Overview Table 113. Eli Lilly Weight Loss Therapeutics Product Table 114. Eli Lilly Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 115. Eli Lilly Recent Development Table 116. Amgen Company Details Table 117. Amgen Business Overview Table 118. Amgen Weight Loss Therapeutics Product Table 119. Amgen Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 120. Amgen Recent Development Table 121. Zafgen Company Details Table 122. Zafgen Business Overview Table 123. Zafgen Weight Loss Therapeutics Product Table 124. Zafgen Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 125. Zafgen Recent Development Table 126. Roche Company Details Table 127. Roche Business Overview Table 128. Roche Weight Loss Therapeutics Product Table 129. Roche Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 130. Roche Recent Development Table 131. Eisai Company Details Table 132. Eisai Business Overview Table 133. Eisai Weight Loss Therapeutics Product Table 134. Eisai Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million) Table 135. Eisai Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Weight Loss Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Appetite Suppression Features Figure 3. Increasing Body Metabolism Features Figure 4. Interfering with the Digestion Absorption Patterns Features Figure 5. Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Specialized Clinics Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Mail Order Pharmacies Case Studies Figure 10. Others Case Studies Figure 11. Weight Loss Therapeutics Report Years Considered Figure 12. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Weight Loss Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Weight Loss Therapeutics Market Share by Regions: 2020 VS 2027 Figure 15. Global Weight Loss Therapeutics Market Share by Regions (2022-2027) Figure 16. Global Weight Loss Therapeutics Market Share by Players in 2020 Figure 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2020 Figure 19. Global Weight Loss Therapeutics Revenue Market Share by Type (2016-2021) Figure 20. Global Weight Loss Therapeutics Revenue Market Share by Type (2022-2027) Figure 21. North America Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Weight Loss Therapeutics Market Share by Type (2016-2027) Figure 23. North America Weight Loss Therapeutics Market Share by Application (2016-2027) Figure 24. North America Weight Loss Therapeutics Market Share by Country (2016-2027) Figure 25. United States Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Weight Loss Therapeutics Market Share by Type (2016-2027) Figure 29. Europe Weight Loss Therapeutics Market Share by Application (2016-2027) Figure 30. Europe Weight Loss Therapeutics Market Share by Country (2016-2027) Figure 31. Germany Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Weight Loss Therapeutics Market Share by Type (2016-2027) Figure 39. Asia-Pacific Weight Loss Therapeutics Market Share by Application (2016-2027) Figure 40. Asia-Pacific Weight Loss Therapeutics Market Share by Region (2016-2027) Figure 41. China Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Weight Loss Therapeutics Market Share by Type (2016-2027) Figure 49. Latin America Weight Loss Therapeutics Market Share by Application (2016-2027) Figure 50. Latin America Weight Loss Therapeutics Market Share by Country (2016-2027) Figure 51. Mexico Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Weight Loss Therapeutics Market Share by Type (2016-2027) Figure 55. Middle East & Africa Weight Loss Therapeutics Market Share by Application (2016-2027) Figure 56. Middle East & Africa Weight Loss Therapeutics Market Share by Country (2016-2027) Figure 57. Turkey Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 61. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 62. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 64. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 65. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 66. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 67. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 68. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 69. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 70. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 71. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 72. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 73. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 74. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us